跳至主要内容
临床试验/NCT05905016
NCT05905016招募中不适用

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

AdventHealth1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
AdventHealth
入组人数
600
试验地点
1
主要终点
Post procedural Reflux Rate

研究概览

简要总结

This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

详细描述

This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

This study will enroll 600 subjects over the next 4 to 5 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 years or older.
  • •Scheduled to undergo POEM

排除标准

  • •Any contraindication to performing endoscopy.
  • •Participation in another research protocol that could interfere or influence the outcomes measures of the present study.

研究组 & 干预措施

Esophageal POEM

Data will be collected for patients under going standard of care Esophageal POEM (E-POEM)

Gastric POEM

Data will be collected for patients under going standard of care Gastric POEM (G-POEM)

Zenker's POEM

Data will be collected for patients under going standard of care Zenker's diverticulum POEM (Z-POEM)

结局指标

主要结局

Post procedural Reflux Rate

时间窗: 12 months

Rate of Long-Term Clinical Success and Post-procedural Reflux Rate Among Patients with Esophageal Dysmotility Undergoing POEM

Long-Term Clinical Efficacy of Z-POEM for the management of Zenker's Diverticulum and Rate of Recurrence

时间窗: 12 months

The main outcome of this study is to evaluate rate of recurrence of symptoms after Z-POEM for Zenker's diverticulum. Recurrence is defined as a return of patient's symptoms (dysphagia, odynophagia) at the time of clinic follow-up.

Long-Term Clinical Efficacy of G-POEM for the management of medically refractory gastroparesis

时间窗: 12 months

The main outcome of the study is to evaluate the proportion of patients who have clinical response to GPOEM. Clinical response is measured by the validated symptom assessment tool (gastroparesis cardinal symptom index - GCSI). Patients with a decrease in GCSI by one or more point will be defined as having a clinical response.

Evaluate the efficacy of POEM for the management of gastrointestinal disease for esophageal motility.

时间窗: 12 months

The main outcome measure is to evaluate the long-term efficacy of POEM for esophageal motility disorders. Efficacy or clinical response is usually assessed using the Eckardt score. An Eckardt score of \< 3 is traditionally defined as treatment response following POEM.

次要结局

未报告次要终点

研究者

发起方
AdventHealth
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验